These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 34920109)
1. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls. Goyal A; Gupta Y; Kalaivani M; Praveen PA; Ambekar S; Tandon N Endocr Pract; 2022 Feb; 28(2):191-198. PubMed ID: 34920109 [TBL] [Abstract][Full Text] [Related]
2. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic]. Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States. Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain. Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269 [TBL] [Abstract][Full Text] [Related]
6. Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic. Tao J; Gao L; Liu Q; Dong K; Huang J; Peng X; Yang Y; Wang H; Yu X Diabetes Res Clin Pract; 2020 Dec; 170():108514. PubMed ID: 33068663 [TBL] [Abstract][Full Text] [Related]
7. Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Tallon EM; Gallagher MP; Staggs VS; Ferro D; Murthy DB; Ebekozien O; Kosiborod MN; Lind M; Manrique-Acevedo C; Shyu CR; Clements MA BMJ Open; 2023 Jul; 13(7):e071475. PubMed ID: 37423628 [TBL] [Abstract][Full Text] [Related]
8. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey]. Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults. Li Y; Tong CH; Bare LA; Devlin JJ JAMA Netw Open; 2021 May; 4(5):e2111634. PubMed ID: 34009346 [TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors. Pedersen OB; Nissen J; Dinh KM; Schwinn M; Kaspersen KA; Boldsen JK; Didriksen M; Dowsett J; Sørensen E; Thørner LW; Larsen MAH; Grum-Schwensen B; Sækmose S; Paulsen IW; Frisk NLS; Brodersen T; Vestergaard LS; Rostgaard K; Mølbak K; Skov RL; Erikstrup C; Ullum H; Hjalgrim H Clin Infect Dis; 2021 Nov; 73(9):e2962-e2969. PubMed ID: 33103182 [TBL] [Abstract][Full Text] [Related]
11. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil. Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Diabetes. Singh AK; Khunti K Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves. Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study. Leong DP; Loeb M; Mony PK; Rangarajan S; Mushtaha M; Miller MS; Dias M; Yegorov S; V M; Telci Caklili O; Temizhan A; Szuba A; Abat MEM; Mat-Nasir N; Diaz ML; Khansaheb H; Lopez-Jaramillo P; Duong M; Teo KK; Poirier P; Oliveira G; Avezum Á; Yusuf S Microbiol Spectr; 2024 Feb; 12(2):e0149223. PubMed ID: 38214526 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers. Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504 [TBL] [Abstract][Full Text] [Related]
18. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]